Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
Active, not recruiting · NCT04383275 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-08-19 | NCT04383275 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Breast cancer institute of Fudan University Cancer Hospital | Shanghai | China | 16 |